Great West Life Assurance CO Atara Biotherapeutics, Inc. Transaction History

Great West Life Assurance CO

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 01, 2022	BUY	$2.85 - $8.73 $9,333 - $28,590	3,275 New	3,275 $12,000
Q2 2021 Aug 11, 2021	SELL	$12.89 - $16.58 $22,325 - $28,716	-1,732 Reduced 34.59%	3,275 $51,000
Q4 2020 Feb 16, 2021	BUY	$12.67 - $26.23 $25,948 - $53,719	2,048 Added 69.21%	5,007 $98,000
Q3 2020 Nov 17, 2020	SELL	$11.92 - $15.87 $3,421 - $4,554	-287 Reduced 8.84%	2,959 $38,000
Q3 2020 Nov 13, 2020	BUY	$11.92 - $15.87 $3,421 - $4,554	287 Added 9.7%	3,246 $42,000

Q2 2020 Aug 17, 2020	SELL	$7.53 - $14.93 $18,312 - $36,309	-2,432 Reduced 45.11%	2,959 $43,000
Q4 2019 Feb 11, 2020	BUY	$10.89 - $16.79 $58,707 - $90,514	5,391 New	5,391 $88,000
Q3 2019 Oct 25, 2019	SELL	$12.03 - $19.94 $57,310 - $94,994	-4,764 Closed	0 $0
Q2 2019 Jul 31, 2019	BUY	$19.05 - $41.04 $90,754 - $195,514	4,764 New	4,764 $0
Q1 2019 May 08, 2019	SELL	$28.4 - $41.74 $93,975 - $138,117	-3,309 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$35.15 - $51.45 $58,173 - $85,149	1,655 Added 100.06%	3,309 $121,000
Q3 2017 Nov 09, 2017	BUY	$13.25 - $17.05 $21,915 - $28,200	1,654	1,654 $27,000

85M

18.4K

51.3K

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $781M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

Stay updated on Great West Life Assurance CO with notifications on news.